Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Journal of Cardiovascular Pharmacology|October 10, 2023
Interleukin-1 Inhibition for the Prevention and Treatment of Heart FailureEhsan Jafree, Marco Giuseppe Del Buono, Justin M Canada, et al.
Journal of Cardiovascular Pharmacology|June 16, 2021
Effect of Canagliflozin Compared With Sitagliptin on Serum Lipids in Patients with Type 2 Diabetes Mellitus and Heart Failure with Reduced Ejection Fraction: A Post-Hoc Analysis of the CANA-HF StudyDave L Dixon, Hayley E Billingsley, Justin M Canada, et al.
Lung|July 9, 2021
Diastolic Dysfunction Contributes to Impaired Cardiorespiratory Fitness in Patients with Lung Cancer and Reduced Lung Function Following Chest RadiationGeorgia K Thomas, Cory R Trankle, Salvatore Carbone, et al.
Cardio-Oncology (London, England)|March 11, 2020
Increased C-reactive protein is associated with the severity of thoracic radiotherapy-induced cardiomyopathyJustin M Canada, Georgia K Thomas, Cory R Trankle, et al.
Diabetes Research and Clinical Practice|September 11, 2022
LPS differentially affects expression of CD14 and CCR2 in monocyte subsets of Post-STEMI patients with hyperglycemiaAnson M Blanks, Lauren N Pedersen, Heather L Caslin, et al.
Cardio-Oncology (London, England)|December 1, 2021
Orthostatic intolerance syndromes after hematopoietic cell transplantation: clinical characteristics and therapeutic interventions in a single-center experienceAlessandra Vecchié, Georgia Thomas, Edoardo Bressi, et al.
Medrxiv : the Preprint Server for Health Sciences|May 4, 2026
INTERLEUKIN-1 RECEPTOR ANTAGONIST LEVELS IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED WITH ANAKINRAJazmin Kelly, Eleonora Mezzaroma, Andrea Roscioni, et al.
ESC Heart Failure|July 5, 2023
Interleukin-1 blockade in heart failure: an on-treatment and off-treatment cardiorespiratory fitness analysisFrancesco Moroni, Michele Golino, Salvatore Carbone, et al.
ESC Heart Failure|January 19, 2018
Low NT-proBNP levels in overweight and obese patients do not rule out a diagnosis of heart failure with preserved ejection fractionLeo F Buckley, Justin M Canada, Marco G Del Buono, et al.
Journal of Cardiovascular Pharmacology|July 15, 2026
INTERLEUKIN-1 RECEPTOR ANTAGONIST LEVELS IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION TREATED WITH ANAKINRAJazmin Kelly, Eleonora Mezzaroma, Andrea Roscioni, et al.
Pageof 7